Great News For Hospital-Acquired infections (OPTR, VPHM)

November 11, 2008 · Filed Under General · Comments Off 

If you have ever personally contracted or know anyone who has contracted hospital or long-term care born internal infection, there is a bit of good news this morning.  Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) released some positive top-line results from its pivotal Phase III clinical study of Optimer’s lead anti-infective drug candidate, OPT-80, in patients with Clostridium difficile Infection (CDI).

ViroPharma (NASDAQ: VPHM) makes the competing drug called Vancocin, and its shares are down 5.7% at $11.85 in pre-market trading.
Read more

    Subscribe to BioHealth Investor BioHealth Investor RSS Feed